Delivery Order SPE2DB20D2014-SPE2DB24FC63W

Award Date 8/1/24
Potential Completion Date 8/2/24
Potential Value $7.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) for the delivery of NALBUPHINE 100 MG/10 ML VIAL 10ML. The contract, which is a Firm Fixed Price Delivery Order with a ceiling value of $1,270.82, has a period of performance through May 30, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NALBUPHINE 100 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $3,332.86. The contract is a Firm Fixed Price Delivery Order, with a completion date of May 30, 2025. The contract is not set aside. Amerisourcebergen Drug Corp holds a larger Indefinite...
This federal contract award, with ID SPE2DX15D6028|Q274, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $78,361.11, is for the delivery of 4539247733 units of NALBUPHINE 10ML 25S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 4, 2017. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established...
This contract award to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, is for the delivery of the drug Nalbuphine 100 mg/10 ml vial with a total ceiling value of $1,457.11. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense, as a delivery order under an existing Indefinite Delivery Contract (IDC) with Amerisourcebergen. This IDC, valued up to $999,999,999, is the primary vehicle for Amerisourcebergen to...
This contract award is for the delivery of NALBUPHINE 200 MG/10 ML VIAL 10ML to the Defense Logistics Agency (DLA). The contract, valued at $3,506.79, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM.gov). The contract has a ceiling value of $3,506.79 and is a Firm Fixed Price Delivery Order with a final completion date of January 31, 2025. The contract is not...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 20 mg/mL ampules of the drug nalbuphine, a non-narcotic analgesic medication, with a ceiling value of $1,963.91 and a completion date of March 10, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,515.19 firm fixed-price delivery order is for the supply of naloxone 2 mg/2 ml syringes. The contract has an ultimate completion date of March 11, 2024 and was awarded on March 8, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,097.84, is for the delivery of 0.4 mg/mL vials of the opioid antagonist drug naloxone. This is a firm fixed-price delivery order contract with a period of performance through March 5, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Naloxone 2 mg/2 ml syringes, with a ceiling value of $1,224.45 and a period of performance through June 12, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corporation holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,651.89 firm fixed-price delivery order is for the supply of 4,566,399,963 units of 2 mg/2 mL naloxone syringes. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC63W
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,298.88 firm fixed price delivery order is for the supply of 4565316249 - NALBUPHINE 200 MG/10 ML VIAL 10ML, a prescription medication. The contract has an ultimate completion date of August 2, 2024. This delivery order appears to be part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to efficiently procure a comprehensive range of medical commodities from Amerisourcebergen to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 10/31/24, 10:43 AM